Conatus Pharmaceuticals Revenue 2012-2019 | CNAT

Conatus Pharmaceuticals revenue from 2012 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Conatus Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $34
2017 $35
2016 $1
2015 $
2014 $
2013 $
2012 $
2011 $
Conatus Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q1 2019 $7
Q4 2018 $7
Q3 2018 $8
Q2 2018 $9
Q1 2018 $10
Q4 2017 $9
Q3 2017 $10
Q2 2017 $10
Q1 2017 $7
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q4 2011
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.010B $0.034B
Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.115B 28.03
Medtronic (MDT) Ireland $144.617B 20.31
Stryker (SYK) United States $81.656B 28.24
Boston Scientific (BSX) United States $59.466B 28.84
Baxter (BAX) United States $44.526B 27.00
EssilorLuxottica Societe Anonyme (ESLOY) France $31.586B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.151B 18.02
Coloplast (CLPBY) Denmark $26.697B 42.62
Lonza Group Ag (LZAGY) Switzerland $26.607B 0.00
Terumo (TRUMY) Japan $23.560B 27.09
Smith & Nephew SNATS (SNN) United Kingdom $20.735B 0.00
ResMed (RMD) United States $19.545B 37.27
Sunny Optical Technology (SNPTF) China $14.643B 0.00
Bio-Rad Laboratories (BIO) United States $10.190B 54.63
Insulet (PODD) United States $9.354B 554.25
Canopy Growth (CGC) Canada $8.712B 0.00
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.062B 21.06
Haemonetics (HAE) United States $6.793B 51.26
Perrigo (PRGO) Ireland $6.499B 11.97
GN STORE NORD (GNNDY) Denmark $6.001B 30.65
Aurora Cannabis (ACB) Canada $5.891B 57.90
GW Pharmaceuticals (GWPH) United Kingdom $4.444B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.753B 62.43
ICU Medical (ICUI) United States $3.439B 22.31
NuVasive (NUVA) United States $3.400B 27.10
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.520B 25.02
Agios Pharmaceuticals (AGIO) United States $2.458B 0.00
National Vision Holdings (EYE) United States $2.257B 48.71
Cardiovascular Systems (CSII) United States $1.754B 0.00
Aphria (APHA) $1.634B 0.00
Phibro Animal Health (PAHC) United States $1.288B 19.30
AtriCure (ATRC) United States $1.035B 0.00
VAREX IMAGING (VREX) United States $1.028B 23.68
Omeros (OMER) United States $0.992B 0.00
PetIQ (PETQ) United States $0.900B 21.27
NanoString Technologies (NSTG) United States $0.896B 0.00
Lantheus Holdings (LNTH) United States $0.885B 23.25
Eagle Pharmaceuticals (EGRX) United States $0.796B 20.29
Cerus (CERS) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
Quanterix (QTRX) United States $0.667B 0.00
LeMaitre Vascular (LMAT) United States $0.624B 37.00
Surmodics (SRDX) United States $0.600B 114.08
TG Therapeutics (TGTX) United States $0.596B 0.00
OraSure Technologies (OSUR) United States $0.439B 20.34
Meridian Bioscience (VIVO) United States $0.410B 12.81
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
BioLife Solutions (BLFS) United States $0.394B 129.63
United Health Products (UEEC) United States $0.374B 0.00
Utah Medical Products (UTMD) United States $0.346B 25.35
Zynex (ZYXI) United States $0.317B 33.65
Owens & Minor (OMI) United States $0.303B 9.09
Bovie Medical (APYX) United States $0.250B 0.00
Vapotherm (VAPO) United States $0.225B 0.00
Cytosorbents (CTSO) United States $0.160B 0.00
Fonar (FONR) United States $0.155B 8.16
Rockwell Medical (RMTI) United States $0.152B 0.00
Chimerix (CMRX) United States $0.144B 0.00
Female Health (VERU) United States $0.129B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
United-Guardian (UG) United States $0.089B 21.08
Chembio Diagnostics (CEMI) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.053B 0.00
MRI INTERVENTNS (MRIC) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Trinity Biotech (TRIB) Ireland $0.036B 0.00
Senestech (SNES) United States $0.028B 0.00
Myomo (MYO) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00